Abiopharma

News list

Director SATO VICKI L 🔴 sold 22.0K shares of Vir Biotechnology, Inc. (VIR) at $10.05 Transaction Date: May 01, 2026 | Filing ID: 029640

Full text

News bot May 4, 2026, 4:36 p.m.
🔍 SATO VICKI L (Director)

Company: Vir Biotechnology, Inc. (VIR)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 22,000
Detailed Transactions and Holdings:
- Sold 22,000 shares of Common Stock at $10.0466 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,078,391.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.